Royal Caribbean Cruises boasts record occupancy and EPS growth, but valuation and market risks remain. Read why RCL stock is ...

Emera outperformed the market with a 12% return, driven by strong earnings and a robust capital plan. Learn why EMRAF stock ...

Apply the formula: Share Price = Dividend / (Risk Rate - Growth Rate). Using variations of risk and growth rates yields a value range for CBA shares from $52.89 (high risk, low growth) to $238 (low ...

“While it may lack the growth options of Exxon, we think this formula can also be successful ... of close to 50% relative to adjusted earnings per share, notes Morningstar director Karen ...

In mid-March here, I (Tom Yeung) wrote about three stocks to sell on an escalating trade war. President Donald Trump was ratcheting his tariff rhetoric, so we highlighted three import-reliant firms to ...

Presentation Operator Good morning. Welcome to Morgan Stanley's First Quarter 2025 Earnings Call. On behalf of Morgan Stanley, I will begin the call with the following information and disclaimers.

Reports Q1 revenue $5.28B, consensus $5.31B.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score ...

The company’s adjusted earnings per share (EPS) of 35 cents missed the Zacks Consensus Estimate of 52 cents by 32.7%. In the year-ago quarter, the company reported an adjusted EPS of 52 cents.

Reports Q1 reported revenue $45.3B and managed revenue $46B, consensus $44.1B.Stay Ahead of the Market: Discover outperforming stocks and ...

Adjusted diluted EPS are expected to be at least $0.55 CER compared to the previously communicated outlook for about $0.50 CER. Sales of the QuantiFERON latent TB test grew about 15% CER as global ...

Q1 2025 preliminary net sales rise 7% CER and adjusted diluted EPS results of at least $0.55 CER both above outlook despite challenging macro environment Full-year 2025 adjusted diluted EPS ...